Abstract
Antibody-based cancer drugs that target the checkpoint proteins CTLA-4, PD-1 and PD-L1 provide marked improvement in some patients with deadly disease......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
